ESO, CNIO and NRCO Conference on Familial Cancer 19/05/2016 – 20/05/2016, Madrid, Spain Chairs: R. Eeles, UK – W.D. Foulkes, CA – M. Robledo, ES – H. Vasen, NL The ESO, CNIO and NRCO Conference [more]
Fifty years ago, when I was just starting out in cancer medicine, our team at the cancer centre attached to Berlin’s Academy of Sciences began our attempts to individualise chemotherapy treatments. We knew that response [more]
People with cancer need their care managed by a team of specialists who work together and learn and improve together. Simon Crompton reports on efforts to achieve such a collaborative approach in delivering prostate cancer [more]
New generations of precision digital scanners are threatening to replace the tool that has been the iconic symbol of pathology for so long. Maria Delaney reports. Glass slides containing tissues and cells are sitting in [more]
With no data from a reliable registry, and no functional national cancer plan, Romania is destined to continue suffering some of the worst cancer rates in Europe. Vlad Mixich tells the story of one dermatologist [more]
The concept is attractive, the results in some patients have been stunning, but what will it take to extend these impressive responses to wider groups of patients? Peter McIntyre reports. There is a growing sense [more]
Once used primarily to detect large polyps and tumours, endoscopy has now become an essential tool for early diagnosis, curative treatment and palliation for gastrointestinal cancer. This is an edited version of a presentation delivered [more]
One of the great myths peddled about cancer control is that it is intrinsically affordable. Nothing could be further from the truth. Preventing and treating cancer is the pinnacle of the health system’s mountain. It [more]
As the European Commission issues its first call for proposals to set up European reference networks, Anna Wagstaff asks: how can these cross-border healthcare structures improve the quality of care received by the almost half [more]
With a five-year overall survival of less than 5%, there is an urgent need to explore new treatment paradigms for pancreatic cancer, including targeting stroma cells, cancer stem cells and metabolic pathways. Ignacio Garrido-Laguna and [more]
This hard-hitting blogpost by Ken Murray, a retired Los Angeles family doctor, helped open up discussions about why doctors routinely administer treatments to dying patients that they would adamantly refuse for themselves. Years ago, Charlie, [more]
2nd ESO-ESMO Latin-American Masterclass in Clinical Oncology 27/04/2016 – 01/05/2016, Bogotà, Colombia Chairs: A. Cervantes, ES – N. Pavlidis, GR – R.A. Stahel, CH Scientific Co-ordinators: M.S. Aapro, CH – F. Cardoso, PT The Masterclass [more]